A carregar...
PATH-04. MDM2/4 AMPLIFICATION AND RISK OF HYPERPROGRESSION IN HIGH-GRADE GLIOMAS TREATED WITH CHECKPOINT INHIBITORS
Checkpoint inhibitors are revolutionizing cancer treatment. However, there are recent reports of systemic cancer patients treated with checkpoint inhibitors with associated hyperprogressive disease (HPD), a ≥2-fold increase in tumor growth rate at first post-treatment imaging, and worse outcomes. So...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216366/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.660 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|